Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-21 Sale |
2021-12-23 4:17 pm |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
15,000 | $32.14 | $482,171 | 477,158 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 5:49 pm |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
14,779 | $47.56 | $702,889 | 72,021 (Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 6:36 pm |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $25.3 | $212,555 | 10,900 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-20 8:20 pm |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
24,846 | $24.6 | $611,105 | 591,886 (Direct) |
View |
| 2020-08-11 Sale |
2020-08-12 5:38 pm |
Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director |
2,499 | $17.19 | $42,952 | 7,499 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-26 Exercise |
2022-04-26 9:42 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
40,000 | $7.38 | 187,561 (Direct) |
View |
| 2022-04-26 Exercise |
2022-04-26 9:42 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
40,000 | $0 | 187,561 (Direct) |
View |
| 2022-04-26 Exercise |
2022-04-26 9:34 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
30,000 | $0 | 664,048 (Direct) |
View |
| 2022-04-26 Exercise |
2022-04-26 9:34 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
30,000 | $4.21 | 664,048 (Direct) |
View |
| 2022-04-18 Option Award |
2022-04-19 7:48 pm |
N/A 2032-04-18 |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
96,250 | $0 | 96,250 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-14 8:09 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO 10% Owner |
34,087 | $1.89 | 537,847 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-14 8:09 pm |
N/A 2024-10-22 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO 10% Owner |
34,087 | $0 | 537,847 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 8:40 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
649 | $24.28 | 77,007 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 8:39 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
4,648 | $24.28 | 503,760 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 8:38 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
2,119 | $24.28 | 66,538 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:26 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer |
52,500 | $0 | 63,521 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:25 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
70,000 | $0 | 128,657 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:24 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
87,500 | $0 | 152,656 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:23 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
218,750 | $0 | 695,908 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-21 9:45 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
40,000 | $0 | 617,900 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-21 9:45 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
40,000 | $4.21 | 617,900 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:49 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
10,000 | $0.87 | 72,021 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:49 pm |
N/A 2023-09-26 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
10,000 | $0 | 72,021 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 7:06 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 7:02 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 7:00 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 6:50 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 6:43 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 6:39 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:35 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer |
102,000 | $0 | 104,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:33 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
250,000 | $0 | 676,144 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:31 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
75,000 | $0 | 127,427 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:29 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. Chief Financial Officer |
62,500 | $0 | 65,386 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:27 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
92,000 | $0 | 143,987 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 6:36 pm |
N/A 2028-05-28 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $0 | 10,900 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 6:36 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
8,400 | $6.98 | 10,900 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 8:20 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
13,000 | $0 | 591,886 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 8:20 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
13,000 | $4.21 | 591,886 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-18 5:33 pm |
N/A 2030-08-16 |
Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-12 5:38 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director |
2,499 | $1.89 | 7,499 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-12 5:38 pm |
N/A 2024-10-22 |
Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director |
2,499 | $0 | 7,499 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:21 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:19 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:18 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:16 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:15 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-05-28 Option Award |
2020-05-29 6:12 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-04-29 Gift |
2020-05-01 5:32 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
2,000 | $0 | 437,990 (Direct) |
View |